-
Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market
[ad_1] Vancouver – (NewMediaWire) – February 12, 2021 – Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN)…
Read More » -
Tauriga Sciences Inc. to Commence Development of its 1st Full Spectrum CBD Infused Edibles Product Line
[ad_1] NEW YORK, NY – (NewMediaWire) – February 12, 2021 – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a…
Read More » -
News
AngioSoma and its Subsidiary SomaCeuticals Announce Amended and Restated Execution of Global License for Multiple Sclerosis Patent
[ad_1] Houston, TX – (NewMediaWire) – February 11, 2021 – AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”), through its wholly-owned subsidiary,…
Read More » -
Reliance Global Group Announces Closing of $12.42 Million Underwritten Offering Including Full Exercise of the Underwriters Over-Allotment Option
[ad_1] Lakewood, NJ – (NewMediaWire) – February 11, 2021 – Reliance Global Group, Inc. (Nasdaq: RELI), a company engaged in…
Read More » -
GeoVax Announces Closing of $10.3 Million Bought Deal Offering
[ad_1] Atlanta, GA – (NewMediaWire) – February 11, 2021 – GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology…
Read More »